Cargando…
Role of EZH2 in Epithelial Ovarian Cancer: From Biological Insights to Therapeutic Target
EZH2 is the catalytic subunit of polycomb repressive complex 2 (PRC2), which generates a methylation epigenetic mark at lysine 27 residue of histone H3 (H3K27me3) to silence gene expression. EZH2 target genes are involved in a variety of biological processes such as stem cell pluripotency, cell prol...
Autores principales: | Li, Hua, Zhang, Rugang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595978/ https://www.ncbi.nlm.nih.gov/pubmed/23494175 http://dx.doi.org/10.3389/fonc.2013.00047 |
Ejemplares similares
-
Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target
por: Wen, Yiping, et al.
Publicado: (2017) -
Insights Into the Role of Mesothelin as a Diagnostic and Therapeutic Target in Ovarian Carcinoma
por: Shen, Jiayu, et al.
Publicado: (2020) -
CHTOP in Chemoresistant Epithelial Ovarian Cancer: A Novel and Potential Therapeutic Target
por: Feng, Xiaojie, et al.
Publicado: (2019) -
EZH2-miRNA Positive Feedback Promotes Tumor Growth in Ovarian Cancer
por: Liu, Ting, et al.
Publicado: (2021) -
Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential
por: Gan, Lu, et al.
Publicado: (2018)